Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    August 2017
  1. ALTENBERGER J, Gustafsson F, Harjola VP, Karason K, et al
    Levosimendan in acute and advanced heart failure: an appraisal of the clinical database and evaluation of its therapeutic applications.
    J Cardiovasc Pharmacol. 2017 Aug 15. doi: 10.1097/FJC.0000000000000533.
    PubMed     Text format     Abstract available


    April 2017
  2. BEI WJ, Wang K, Li HL, Lin KY, et al
    Safe Hydration Volume to Prevent Contrast-Induced Acute Kidney Injury and Worsening Heart Failure in Patients with Heart Failure and Preserved Ejection Fraction Following Cardiac Catheterization.
    J Cardiovasc Pharmacol. 2017 Apr 27. doi: 10.1097/FJC.0000000000000502.
    PubMed     Text format     Abstract available


    February 2017
  3. KOLPAKOV MA, Tilley DG, Sabri A
    Galphaq Signaling in the Regulation of Autophagy and Heart Failure.
    J Cardiovasc Pharmacol. 2017 Feb 3. doi: 10.1097/FJC.0000000000000471.
    PubMed     Text format    


    May 2016
  4. ALSKAF E, Tridente A, Al-Mohammad A
    Tolvaptan for Heart Failure, Systematic Review and Meta-Analysis of Trials.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  5. KAMIMURA D, Uchino K, Ishigami T, Hall ME, et al
    Activation of Peroxisome Proliferator-Activated Receptor gamma Prevents Development of Heart Failure with Preserved Ejection Fraction; Inhibition of Wnt-beta-catenin Signaling as a Possible Mechanism.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  6. HILLGAARD TK, Andersen A, Andersen S, Vildbrad MD, et al
    Levosimendan Prevents Pressure-Overload-induced Right Ventricular Failure.
    J Cardiovasc Pharmacol. 2016;67:275-82.
    PubMed     Text format     Abstract available


    February 2016
  7. VAN TASSELL BW, Abouzaki NA, Erdle CO, Carbone S, et al
    Interleukin-1 Blockade In Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  8. SI L, Xu J, Yi C, Xu X, et al
    Asiatic Acid Attenuates the Progression of Left Ventricular Hypertrophy and Heart Failure Induced by Pressure Overload by Inhibiting Myocardial Remodeling in Mice.
    J Cardiovasc Pharmacol. 2015;66:558-68.
    PubMed     Text format     Abstract available


    November 2015
  9. HOEKER GS, Hanafy MA, Oster RA, Bers DM, et al
    Reduced Arrhythmia Inducibility with Calcium/Calmodulin-Dependent Protein Kinase II Inhibition in Heart Failure Rabbits.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  10. WANG ZQ, Zhang R, Chen MT, Wang QS, et al
    Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    J Cardiovasc Pharmacol. 2015;66:270-5.
    PubMed     Text format     Abstract available


    August 2015
  11. IKEDA T, Iwanaga Y, Watanabe H, Morooka H, et al
    The Effects of Long-Term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  12. LIU C, Zhao Q, Zhen Y, Zhai J, et al
    The Effect of Corticosteroid on Renal Water and Sodium Excretion in Symptomatic Heart Failure: Prednisone for Renal Function Improvement Evaluation Study.
    J Cardiovasc Pharmacol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  13. LJUBOJEVIC S, Bers DM
    Nuclear calcium in cardiac myocytes.
    J Cardiovasc Pharmacol. 2015;65:211-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: